This question has been answered by the relevant Government Department.
Question text
Lord Sharkey to ask Her Majesty's Government, further to the remarks by Baroness Blackwood of North Oxford on 1 May 2019 (HL Deb, col 1020) that they intend to "ensure that the review takes into account the benefits offered by new treatments for severe life-threatening and rare diseases", what plans they have to provide assurances that NICE will not end the use of rarity as a decision modifier in its highly specialised technology appraisal process. HL9379
Legend for business item text
† Item that is new or altered.
* Item is an oral question.
Numbers starting HL are unique identifiers for written questions, Bills or papers.
Date Answered
Wednesday 28 October 2020
Member's Registered Interests
There are no interests to show.
Main Member
Lord Sharkey
Liberal Democrat
Life peer